Baker Bros. Advisors’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-241,684
| Closed | -$115K | – | 94 |
|
|
2025
Q1 | $115K | Sell |
241,684
-555,776
| -70% | -$265K | ﹤0.01% | 85 |
|
|
2024
Q4 | $805K | Hold |
797,460
| – | – | 0.01% | 90 |
|
|
2024
Q3 | $1.36M | Hold |
797,460
| – | – | 0.01% | 82 |
|
|
2024
Q2 | $2.03M | Hold |
797,460
| – | – | 0.03% | 80 |
|
|
2024
Q1 | $3.33M | Hold |
797,460
| – | – | 0.04% | 66 |
|
|
2023
Q4 | $2.65M | Sell |
797,460
-351,880
| -31% | -$1.17M | 0.03% | 69 |
|
|
2023
Q3 | $2.3M | Hold |
1,149,340
| – | – | 0.01% | 83 |
|
|
2023
Q2 | $3.63M | Hold |
1,149,340
| – | – | 0.02% | 82 |
|
|
2023
Q1 | $3.99M | Hold |
1,149,340
| – | – | 0.02% | 75 |
|
|
2022
Q4 | $5.9M | Buy |
1,149,340
+778,753
| +210% | +$4M | 0.04% | 75 |
|
|
2022
Q3 | $3.67M | Buy |
+370,587
| New | +$3.67M | 0.02% | 89 |
|